Idiopathic Hypereosinophilic Syndrome in an Elderly Female: A Case Report.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
23 Mar 2019
Historique:
entrez: 24 3 2019
pubmed: 25 3 2019
medline: 30 11 2019
Statut: epublish

Résumé

BACKGROUND Hypereosinophilic syndrome (HES) is defined as hypereosinophilia with eosinophil mediated organ damage or dysfunction, provided that other causes of organ damage have been excluded. CASE REPORT An 83-year-old female presented with worsening dyspnea for 3 weeks. She was initially diagnosed with bronchitis and prescribed oral antibiotics along with prednisone taper. However, her dyspnea continued to worsen requiring hospitalization. Physical examination was significant for signs of volume overload. Laboratory investigations were notable for leukocytosis with eosinophilia, elevated BNP (brain natriuretic peptide) and troponin. Electrocardiogram (ECG) showed normal sinus rhythm with non-specific ST-T wave changes. Computed tomography (CT) scan of the chest showed pulmonary edema, bilateral peripheral ground glass opacities, and pleural effusions. Transthoracic echocardiogram (TTE) revealed an ejection fraction (EF) of 45%. She was diagnosed with NSTEMI (non-ST-elevation myocardial infarction) with new onset heart failure; appropriate management was initiated. Left heart catheterization did not show any significant obstructive lesions. Presence of peripheral ground glass opacities on the CT chest scan and eosinophilia raised suspicion for HES. Thorough HES workup was done, all tests came back negative except for elevated serum IgE level. Cardiac biopsy returned positive for eosinophilic myocarditis. Bone marrow biopsy showed 20% eosinophils. Positron emission tomography (PET) scan did not show any hypermetabolic lesions to suggest malignancy. The patient was managed for idiopathic HES with high dose steroids resulting in significant clinical improvement. CONCLUSIONS About 40% of patient with HES manifest cardiac involvement, and one quarter of patients with HES have pulmonary involvement with variable radiologic findings. Steroids remain the mainstay treatment for idiopathic HES.

Identifiants

pubmed: 30902963
pii: 912747
doi: 10.12659/AJCR.912747
pmc: PMC6441311
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-384

Références

J Allergy Clin Immunol. 2010 Jul;126(1):179-81
pubmed: 20639012
Respir Med. 2011 Jan;105(1):114-21
pubmed: 21036585
J Allergy Clin Immunol. 2012 Sep;130(3):607-612.e9
pubmed: 22460074
NDT Plus. 2009 Oct;2(5):379-81
pubmed: 25949349
Clin Kidney J. 2013 Jun;6(3):272-6
pubmed: 26064485
Am J Med Sci. 2017 Nov;354(5):486-492
pubmed: 29173361
Front Med (Lausanne). 2017 Dec 22;4:240
pubmed: 29312946
Ann Intern Med. 1982 Jul;97(1):78-92
pubmed: 7046556
Blood. 1993 Sep 1;82(5):1553-60
pubmed: 8364205

Auteurs

Faiza Khalid (F)

Department of Internal Medicine, University Hospital Cleveland Medical Center/Case Western Reserve University, Cleveland, OH, USA.

Fernando Holguin (F)

Department of Pulmonary, Critical Care and Sleep Medicine, University of Colorado, Denver, CO, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH